Date Name Title Filing Type Shares Traded Price Total Held
Nov 13, 2012
Director
Director Form 4 Open market or private sale of non-derivative or derivative security 5,000 $148.00 132,772
Jun 09, 2010
Director
Director Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 5,000 $25.43 132,772
Sep 06, 2011
SVP Research and Development S
SVP Research and Development S Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 82,818 $11.64 133,168
Jan 05, 2005
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 3,430 -- 133,332
Nov 29, 2012
Director, Chairman of the Board
Director, Chairman of the Board Form 4 Open market or private sale of non-derivative or derivative security 1,800 $175.95 133,776
Jan 05, 2005
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 46,666 -- 134,332
Oct 28, 2014
Director, President & CEO
Director, President & CEO Form 4 Open market or private sale of non-derivative or derivative security 3,318 $402.54 134,448
May 20, 2013
SVP Finance and Admin CFO and
SVP Finance and Admin CFO and Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 1,260 $266.64 134,543
Jan 02, 2018
Director
Director Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 15,000 $23.84 134,772
Nov 28, 2012
Director, Chairman of the Board
Director, Chairman of the Board Form 4 Open market or private sale of non-derivative or derivative security 7,004 $175.03 135,576

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.